Photo of Robert Rosenson
Accepting New Patients
Robert Rosenson, MD
Cardiology
    • Position
    • PROFESSOR | Medicine, Cardiology
    • Specialty
    • Cardiology
    • Language
    • English
    • Hospital Affiliation
    • The Mount Sinai Hospital
    • Phone
    • The Lauder Family Cardiovascular Ambulatory Center 212-427-1540
    • New York Smart Health (Mount Sinai Affiliate) 718-439-5111
    • Mount Sinai Comprehensive Health Program Downtown 212-604-1704
Request an Appointment
1190 Fifth Avenue 1st Floor
New York, NY 10029
Phone: 212-427-1540
7405 5th Avenue
Brooklyn, NY 11209
Phone: 718-439-5111
275 Seventh Ave 12th Floor
New York, NY 10001
Phone: 212-604-1704

Robert S. Rosenson, MD
FACC, FACP, FAHA, FNLA, FACCP
(inactive)

 

Robert S. Rosenson, MD, is Professor of Medicine at the Icahn School of Medicine at Mount where he serves as Director of Cardiometabolic Disorders. He is a Fellow of the American Heart Association Council on Epidemiology and Prevention, Fellow of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology, Fellow of the National Lipid Association and a past Fellow of the American College of Chest Physicians (inactive).  He has been the recipient of a number of awards and honors, including the Ground-Breaking Doctors Award from Chicago magazine. Dr. Rosenson is Co-Editor-In-Chief, Cardiovascular Drugs and Therapy, effective February 1, 2016 and has been elected to the European Academy of Sciences.  

Dr. Rosenson earned his medical degree from Tulane University in New Orleans, Louisiana where he conducted research on prostaglandin metabolism in coronary arteries.  This work was recognized when he was awarded the Querens-Rives-Shore Award for best thesis in Cardiology. He then served his residency in medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He later completed a fellowship in cardiovascular medicine at the University of Chicago that was followed by an additional year of training as a Research Associate in lipoprotein metabolism.

              

Dr. Rosenson is a Diplomate of the American Board of Internal Medicine, with a subspecialty in cardiovascular disease, the National Board of Medical Examiners, and National Lipid Association.  He currently serves on a number of committees for professional societies.  He has served on nine committees for the American College of Cardiology, and he served as a member of the Expert Document Committee for the American College of Cardiology and ACCF Representative to the ADA Aspirin Therapy in Diabetes Position Statement. He has been extensively involved with the National Lipid Association where he serves a National Board Member and Northeast Lipid Association Board Member. Dr. Rosenson served as Co-Chair for the task force on HDL biology, and he is the current Chair of the Statin Safety Expert Muscle Document Committee. Dr. Rosenson led three international working groups on HDL that resulted in seminal articles on HDL nomenclature, HDL and macrophage cholesterol, and HDL functionality.

Dr. Rosenson has been involved in numerous grant-supported research investigations studying the effects of lipid-lowering therapy, hypoglycemic therapy, and antihypertensive agents in inflammation, thrombogenesis, and rheology. His laboratory was the first to demonstrate that statins reduce pro-inflammatory cytokine production. He has continued this work through mechanistic studies on inflammatory markers with studies on fenofibrate. Most recently, he has conducted research with selective inhibitors of inflammatory pathways such as lipoprotein-associated phospholipase A2, and secretory phospholipase A2. He has made important contributions concerning the prognostic significance of lipoprotein subclasses in coronary atherosclerosis, cardiovascular events and prediction of type 2 diabetes. He has served as Principal Investigator on a number of NIH-funded research studies, pharmaceutical-sponsored drug trials, and multicenter studies. He served as Global Principal Investigator of the PLASMA I, PLASMA II and FRANCIS trials. He has authored 230 peer-review journal articles, and nearly 600 book chapters, abstracts, and electronic publications for Up To Date Medicine. 

Certifications

American Board of Clinical Lipidology
Cardiovascular Disease
American Board of Internal Medicine

Clinical Focus

Education

MD, Tulane University

Residency, Internal Medicine
Brigham and Women's Hospital, Harvard Medical School

Fellowship, Cardiovascular
University of Chicago Hospitals

Language

English

Download the CV